This year, The European Association for Clinical Pharmacology and Therapeutics (EACPT) 2024 was held in Rotterdam, The Netherlands. David Burger had the opportunity to present a poster about the development of an online tool for the management of drug-drug interactions (DDIs) within the MISSION clinical trial. Currently, DDI management of investigational medicinal products (IMPs) is described in the Study Protocol and the IB. This is in contrast with licensed drugs that are included in automated clinical decision support systems and pharmacy dispensing programs. We started this study to improve the quality of DDI management with IMPs. The process of this study is easily transferable to other IMPs. Read for all the details on the poster!